Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand PLC, CVS Health Corp.

Author's Avatar
Jan 11, 2015

According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand PLC, CVS Health Corp.

Six Flags Entertainment Corp (SIX, Financial): Chairman, President & CEO James Reid-anderson sold 150,700 Shares

Chairman, President & CEO of Six Flags Entertainment Corp (SIX, Financial) James Reid-anderson sold 150,700 shares on 01/05/2015 at an average price of $43.12. Six Flags Inc. is a Delaware Corporation. The Company owns and operates regional theme, water and zoological parks. Six Flags Entertainment Corp has a market cap of $4.05 billion; its shares were traded at around $43.30 with a P/E ratio of 34.50 and P/S ratio of 3.71. The dividend yield of Six Flags Entertainment Corp stocks is 4.46%. Six Flags Entertainment Corp had an annual average earnings growth of 23.10% over the past 10 years.

Six Flags Entertainment Corp. announced its 2014 third quarter results. The Company reported net sales of $542 million and net income of $124 million.

Chairman, President & CEO James Reid-anderson sold 950,700 shares of SIX stock in November and January. VP, Chief Accounting Officer Leonard A Russ, Senior VP - Marketing Brett Petit¸ SVP- Administration, and Secretary Walter Hawrylak together sold 41,187 shares of SIX stock in September and October.

Gilead Sciences Inc (GILD, Financial): Chairman and CEO John C Martin sold 150,000 Shares

Chairman and CEO of Gilead Sciences Inc (GILD, Financial) John C Martin sold 150,000 shares on 01/05/2015 at an average price of $95.12. Gilead Sciences Inc was incorporated in Delaware on June 22, 1987. Gilead Sciences Inc has a market cap of $154.2 billion; its shares were traded at around $102.21 with a P/E ratio of 17.70 and P/S ratio of 8.27. Gilead Sciences Inc had an annual average earnings growth of 8.20% over the past 5 years.

Gilead Sciences Inc. reported its 2014 third quarter financial results with revenues of $6.0 billion and net income of $2.7 billion.

Chairman and CEO John C Martin sold 712,508 shares of GILD stock from September to January. EVP, CFO Robin L Washington sold 101,652 shares of GILD stock in August and November. EVP, Corp & Med Affairs Gregg H Alton, EVP Commercial Ops Paul Rutherford Carter, Director Richard James Whitley, Director John Francis Cogan, and President and COO John F Milligan together sold 185,823 shares of GILD stock in December and January.

Ingersoll-Rand PLC (IR, Financial): Chairman, President and CEO Michael W Lamach sold 150,000 Shares

Chairman, President and CEO of Ingersoll-Rand PLC (IR, Financial) Michael W Lamach sold 150,000 shares on 01/02/2015 at an average price of $63.01. Ingersoll-Rand PLC is an Irish public limited company, incorporated in 2009. Ingersoll-rand Plc has a market cap of $16.39 billion; its shares were traded at around $61.75 with a P/E ratio of 23.70 and P/S ratio of 1.36. The dividend yield of Ingersoll-rand Plc stocks is 1.62%. Ingersoll-rand Plc had an annual average earnings growth of 2.90% over the past 5 years.

Ingersoll-Rand PLC announced revenues of $3.4 billion and net income of $291.3 million for its 2014 third quarter financial results.

Chairman, President and CEO Michael W Lamach sold 150,000 shares of IR stock on 01/02/2015 at the average price of 63.01. Senior Vice President Gary S Michel, VP & Corporate Controller Richard Weller¸ EVP, Industrial Segment Robert Zafari, and Director Jared L Cohon together sold 62,998 shares of IR stock in July, October, November, and December.

CVS Health Corp (CVS, Financial): President and CEO Larry J Merlo sold 144,144 Shares

President and CEO of CVS Health Corp (CVS, Financial) Larry J Merlo sold 144,144 shares on 01/05/2015 at an average price of $94.3. CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. Cvs Health Corp has a market cap of $112.25 billion; its shares were traded at around $97.92 with a P/E ratio of 25.50 and P/S ratio of 0.86. The dividend yield of Cvs Health Corp stocks is 1.12%. Cvs Health Corp had an annual average earnings growth of 12.60% over the past 10 years. GuruFocus rated Cvs Health Corp the business predictability rank of 4.5-star.

CVS Health Corp. declared its 2014 third quarter results with revenues of $35.0 billion and net income of $0.9 billion.

President and CEO Larry J Merlo sold 144,144 shares of CVS stock on 01/05/2015 at the average price of 94.3. EVP & President, CVS/caremark Jonathan C Roberts, SVP & Pres, CVS/minuteclinic Andrew Sussman, EVP, Chief Medical Officer Troyen A Brennan, EVP Per Gh Lofberg, and EVP, President-CVS/pharmacy Helena Foulkes together sold 534,615 shares of CVS stock in November and January.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.